AIA (Aspergillus Induced Asthma) Panel

The AIA (Aspergillus-Induced Asthma) Panel is a comprehensive diagnostic panel used to evaluate asthma that may be triggered or worsened by Aspergillus fumigatus, a common environmental fungus. It combines fungal culture, microscopic staining, Aspergillus-specific IgE, total IgE, and sputum eosinophil analysis to assess allergic sensitisation and fungal involvement in the airways. This panel helps identify allergic responses to Aspergillus and supports the diagnosis of conditions such as allergic fungal airway disease or allergic bronchopulmonary aspergillosis (ABPA).

Who Should Get This Test Done?

This test may be recommended for:

●     Individuals with asthma that remains poorly controlled despite regular treatment.

●     Individuals with recurrent wheezing, persistent cough, or breathlessness suspected to be triggered by fungal exposure.

●     Individuals with a history of repeated chest infections or mucus plugs along with asthma.

●     Individuals suspected of having allergic bronchopulmonary aspergillosis (ABPA) or fungal-associated airway disease.

●     Individuals whose healthcare provider recommends evaluation for fungal allergy as a cause of respiratory symptoms.

 Why Consider This Test?

    This test:

●     Evaluates multiple markers associated with Aspergillus-related asthma in a single panel.

●     Helps identify allergic sensitisation to Aspergillus fumigatus.

●     Detects evidence of fungal presence in respiratory specimens through culture and staining.

●     Assesses airway inflammation using sputum eosinophil analysis and total IgE levels.

●     Supports accurate diagnosis and helps guide appropriate treatment strategies.

More Information

The AIA Panel combines microbiological, immunological, and inflammatory markers to provide a detailed assessment of Aspergillus-related respiratory disease. It includes fungal culture and staining to detect fungal organisms, Aspergillus fumigatus-specific IgE to identify allergic sensitisation, total IgE to assess the overall allergic response, and sputum eosinophils to evaluate airway inflammation. The findings are interpreted alongside the patient’s symptoms, imaging studies, pulmonary function tests, and clinical history for a comprehensive evaluation.

Other Names

●     Aspergillus-Induced Asthma Panel

●     Aspergillus Allergy Panel

●     Allergic Bronchopulmonary Aspergillosis (ABPA) Evaluation Panel

●     Aspergillus Respiratory Allergy Panel

●     Fungal Asthma Diagnostic Panel